EyeCRO are Experts in preclinical efficacy studies in ophthalmic retinopathy, pharmacokinetics, both in vivo and in vitro for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in retina preclinical efficacy, oxygen-induced retinopathy, and ophthalmic pharmacokinetics for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in Laser CNV, Retina preclinical efficacy, and Ophthalmic toxicology for clinical and precise formulation services.

Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research

MiDROPS™

The Microemulsion Drug Ocular Penetration System (MiDROPS™) is a transformative technology for the development of eyedrop formulations.  This patented platform allows for the preparation and delivery of lipophilic agents to tissues in both the front and back of the eye.  MiDROPS™ are prepared using materials already approved by the US Food and Drug Administration for use in ophthalmic products, and by nature are intrinsically thermo-stable.

In-Vivo

EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible.

Gut microbes linked to major autoimmune eye disease

One major cause of human blindness is autoimmune uveitis, which is triggered by the activation of T … Read More

Proteomic Studies of Age-Related Ocular Diseases

A Cleveland Clinic lab has found evidence to support the theory that age-related macular … Read More

Protecting Your Eyes From Macular Degeneration

Macular degeneration, also known as age-related macular degeneration (or AMD) is the most common … Read More

More News

Wednesday, August 19th, 2015 at 11:20am
Another demonstration of how important the microbiome is! http://t.co/DaLudzngp6
Saturday, August 15th, 2015 at 4:53pm
RT @CleClinicMD: Focused proteomic studies look to find biomarker candidates for age-related ocular diseases http://t.co/bffhCLm9kh http://…
Friday, August 14th, 2015 at 10:15am
Team begins first clinical trial of stem cell-based retinitis pigmentosa treatment http://t.co/d9GvFbgFHt
Friday, August 14th, 2015 at 10:04am
$ONCE has several programs in for many indications and is led by fantastic scientists. wouldn't bet against them https://t.co/KeCpTAti90
Ophthalmic Contract Research